CNS Pharmaceuticals (CNSP) will present at the 6th Glioblastoma Drug Development Summit being held February 18-20, 2025 in Boston, MA. As part ...

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS ...

Thanks to its capacity to detect patterns and stay consistent, machine learning is a great tool for CNS behaviour studies.

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a generative AI software leader in clinical trial analytics, announces that it will present new data ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

Wednesday, Feb. 26: 7:30 p.m. vs. Clifton Central in Fieldcrest Regional Thursday: 6 p.m. vs. Mt. Pulaski in R-B Regional ...